Boston-based Insilico, which uses AI for drug discovery and has extensive operations in China, raised a $110M Series E led by Value Partners at a $1B+ valuation (Saritha Rai/Bloomberg)
Saritha Rai / Bloomberg: Boston-based Insilico, which uses AI for drug discovery and has extensive operations in China, raised a $110M Series E led by Value Partners at a $1B+ valuation — US-based Insilico, which has extensive operations in China, secured $110 million in a financing round led by Value Partners Group.
Saritha Rai / Bloomberg:
Boston-based Insilico, which uses AI for drug discovery and has extensive operations in China, raised a $110M Series E led by Value Partners at a $1B+ valuation — US-based Insilico, which has extensive operations in China, secured $110 million in a financing round led by Value Partners Group.
